Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
12/1999
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/22/1999CN1239102A Electromagnetized plant protein and its preparing process and application
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999WO1999064045A1 Novel therapeutic agents for membrane transporters
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063984A1 Novel sodium channel drugs and uses
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063932A2 Multibinding agents that modulate the 5-ht transporter
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319153A1 Novel sodium channel drugs and uses
12/16/1999CA2319142A1 Novel therapeutic agents for membrane transporters
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318806A1 Multibinding agents that modulate the 5-ht transporter
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/09/1999WO1999062563A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/09/1999CA2299389A1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/01/1999EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
11/1999
11/25/1999WO1999059560A1 Glucose transport modulators and uses therefor
11/23/1999US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
11/04/1999WO1999055900A2 Gcp
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
10/1999
10/27/1999CN1233326A Process for determining the status of an organism by peptide measurement
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/12/1999US5965408 Amplifying heterologous, single stranded dna complementary to a gene with random oligonucleotide primers; prematurely terminating synthesis forming variable length strands; denaturing and reannealing strands; repeating cycle
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050657A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2325721A1 Corticotropin releasing factor receptor 1-deficient mice
10/05/1999CA2074182C Process for the reactivation of denatured protein
09/1999
09/28/1999US5958424 Recombinant chicken anemia virus particle
09/23/1999WO1999047253A1 Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
09/21/1999US5955433 Method of thrombin inhibition
08/1999
08/19/1999WO1999041612A1 Methods and compositions for diagnosis of hepatoma
08/19/1999WO1999023236A9 Method of dna shuffling
08/19/1999CA2321160A1 Methods and compositions for diagnosis of hepatoma
08/18/1999EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48